<div class="container">
    <div class="row">
        <div id="speaker-detail" class="col-lg-6 col-lg-offset-3">
            <div class="row">
                <button title="Close (Esc)" type="button" class="mfp-close">Ã—</button>
                <div class="col-md-4 col-lg-4">
                    <img class="img-responsive" src="img/speaker_302.png" alt="" />
                    <br />
                </div>
                <div class="col-md-8 col-lg-8">
                    <h2>Sr. Engineer, Process Development, Biogen Idec</h2>
                    <h3>Scientific Director of Clinical Laboratory Sciences, Genzyme Sanofi.</h3>
                    <p>Dr. Eric Peng received his B.S in Chemical Engineering from National Taiwan University and the Ph.D in Chemical and Biological Engineering from State University of New York at Buffalo. He has joined Biogen Idec since 2012. He is an expert in cell culture process scale-up across bench, pilot and large scale (15,000L) manufacture bioreactor and specialized at Raw material qualification, cell line development, bioreactor-associated cell damaging, high seed ATF/TFF bioreactor process and advanced sparger design. In the Biogen Idec, Eric serves as the project leader in collaboration with large-scale manufacture, analytical development, GMP quality control, technical transfer and Biological raw material supply chain. He is also experienced in communication with external vendors, CRO, supplier and academic laboratory.
                    </p>
                </div>
            </div>
        </div>
    </div>
</div>